Immunate 250 IU FVIII/190 IU VWF powder and solvent for solution for injection Malta - English - Medicines Authority

immunate 250 iu fviii/190 iu vwf powder and solvent for solution for injection

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 250 iu von willebrand factor, human 190 iu - antihemorrhagics

Immunate 500 IU FVIII/375 IU VWF powder and solvent for solution for injection Malta - English - Medicines Authority

immunate 500 iu fviii/375 iu vwf powder and solvent for solution for injection

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 500 iu von willebrand factor, human 375 iu - antihemorrhagics

Immunate 1000 IU FVIII/750 IU VWF powder and solvent for solution for injection Malta - English - Medicines Authority

immunate 1000 iu fviii/750 iu vwf powder and solvent for solution for injection

takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 1000 iu von willebrand factor, human 750 iu - antihemorrhagics

OCTANATE 1000 Israel - English - Ministry of Health

octanate 1000

dover medical & scientific equipment ltd, israel - factor viii - powder and solvent for solution for injection - factor viii 1000 iu/vial - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency).this preparation does not contain von willebrand factor in pharmacologically effective quantities and is therefore not indicated in von willebrand’s disease.

OCTANATE 500 Israel - English - Ministry of Health

octanate 500

dover medical & scientific equipment ltd, israel - factor viii - powder and solvent for solution for injection - factor viii 500 iu/vial - coagulation factor viii - treatment and prophylaxis of bleeding in patients with haemophilia a (congenital factor viii deficiency)this preparation does not contain von willebrand factor in pharmacologically effective quantities and is therefore not indicated in von willebrand's disease.

CSL Hong Kong Biostate Human Coagulation Factor VIII 250IU/von Willebrand factor 500IU complex, Powder for injection (50 IU/mL F Australia - English - Department of Health (Therapeutic Goods Administration)

csl hong kong biostate human coagulation factor viii 250iu/von willebrand factor 500iu complex, powder for injection (50 iu/ml f

csl behring australia pty ltd - von willebrand factor, quantity: 500 iu; factor viii, quantity: 250 iu - injection, diluent for - excipient ingredients: water for injections - biostate is indicated for: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. - the prophylaxis and treatment of non-surgical and surgical bleeding associated with fviii deficiency due to haemophilia a.